Suivre
Paola Bonaventura
Paola Bonaventura
Chercheur assistant au Centre Léon Bérard
Adresse e-mail validée de lyon.unicancer.fr
Titre
Citée par
Citée par
Année
Cold tumors: a therapeutic challenge for immunotherapy
P Bonaventura, T Shekarian, V Alcazer, J Valladeau-Guilemond, ...
Frontiers in immunology 10, 168, 2019
9012019
Zinc and its role in immunity and inflammation
P Bonaventura, G Benedetti, F Albarède, P Miossec
Autoimmunity reviews 14 (4), 277-285, 2015
7712015
Medical applications of Cu, Zn, and S isotope effects
F Albarede, P Télouk, V Balter, VP Bondanese, E Albalat, P Oger, ...
Metallomics 8 (10), 1056-1070, 2016
802016
Human endogenous retroviruses (HERVs): shaping the innate immune response in cancers
V Alcazer, P Bonaventura, S Depil
Cancers 12 (3), 610, 2020
542020
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ...
Science Advances 8 (4), eabj3671, 2022
442022
Differential effects of TNF-α and IL-1β on the control of metal metabolism and cadmium-induced cell death in chronic inflammation
P Bonaventura, A Lamboux, F Albarede, P Miossec
PLoS One 13 (5), e0196285, 2018
352018
A feedback loop between inflammation and Zn uptake
P Bonaventura, A Lamboux, F Albarede, P Miossec
PLoS One 11 (2), e0147146, 2016
312016
Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis
P Bonaventura, G Courbon, A Lamboux, F Lavocat, H Marotte, F Albarède, ...
Scientific reports 7 (1), 2415, 2017
292017
Neoepitopes-based vaccines: challenges and perspectives
V Alcazer, P Bonaventura, L Tonon, S Wittmann, C Caux, S Depil
European Journal of Cancer 108, 55-60, 2019
242019
Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol. 2019; 10: 168
P Bonaventura, T Shekarian, V Alcazer, J Valladeau-Guilemond, ...
Epub 2019/02/26. https://doi. org/10.3389/fimmu. 2019.00168 PMID: 30800125, 2019
232019
IL-17A and TNF-α increase the expression of the antiapoptotic adhesion molecule amigo-2 in arthritis synoviocytes
G Benedetti, P Bonaventura, F Lavocat, P Miossec
Frontiers in Immunology 7, 196070, 2016
202016
Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation
P Bonaventura, A Lamboux, F Albarède, P Miossec
PLoS One 12 (7), e0180879, 2017
182017
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
V Alcazer, P Bonaventura, L Tonon, E Michel, V Mutez, C Fabres, ...
American Journal of Hematology 97 (9), 1200-1214, 2022
92022
Cancer vaccines: what’s next?
S Depil, P Bonaventura, V Alcazer
Oncotarget 10 (40), 3985, 2019
42019
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy
M Mallet, RE Boulos, V Alcazer, P Bonaventura, Y Estornes, N Chuvin, ...
European Journal of Cancer 171, 96-105, 2022
32022
Nouvelles approches vaccinales en cancérologie
S Depil, P Bonaventura, V Alcazer, L Tonon
Bulletin du Cancer 105, S113-S120, 2018
12018
Changement de l’homéostasie du Zinc et du Cadmium par l’inflammation chronique et nouvelles options thérapeutiques pour le traitement de l’arthrite
P Bonaventura
Lyon, 2016
12016
Human Endogenous Retroviruses represent a source of shared tumor epitopes inducing high-avidity cytotoxic T cells for cancer immunotherapy.
P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ...
CANCER IMMUNOLOGY RESEARCH 10 (12), 2022
2022
Abstract B49: Human Endogenous Retroviruses represent a source of shared tumor epitopes inducing high-avidity cytotoxic T cells for cancer immunotherapy
P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ...
Cancer Immunology Research 10 (12_Supplement), B49-B49, 2022
2022
IDENTIFICATION OF SHARED TUMOR EPITOPES FROM ENDOGENOUS RETROVIRUSES INDUCING HIGH AVIDITY CYTOTOXIC T CELLS FOR CANCER IMMUNOTHERAPY
P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 9, A719-A719, 2021
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20